LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.
This week in medtech deals over $277.1 million in funding was raised across eight deals, in addition to a number of other undisclosed deals that were announced. Here are some of the top deals tracked:
Start a Free Trial to Medtech Startup Tracker Today
Top Deals – Medtech Fundraising Transactions for the Week|
Company |
Type |
Amount Raised |
Round |
|
Diagnostic tests for expecting mothers |
$100,000,000 |
Series E |
|
|
Fluorescence-guided surgery technology |
$7,000,000 |
Series A |
|
|
Insulin dosing management technology |
$21,000,000 |
Financing |
Top deals for the week are based on publicly available information. At this time of this article’s publication, new deals for the week may have been announced.
LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape. Here are some of the interesting startups we’ve recently profiled:
Ronovo Surgical raised an undisclosed amount from Series A roundThe Shanghai-based emerging medtech company is focused on developing digital surgery and minimally invasive surgical solutions that are geared towards the underserved Chinese market. The company, founded by veterans from the surgical and industrial robotic industries. Ronovo’s next-generation surgical system will incorporate robotics and digital solutions that will democratize advanced surgical techniques. Key strategics in the robotic surgery market include Auris Health, Intuitive Surgical, and Stryker.
Ceribell closes Series C round for $53M
Funds from the round will be used to support the commercialization of the company’s portable electroencephalography (EEG) device, Clarity. Ceribell has also announced that the financing will be used to research and develop its artificial intelligence and EEG technologies. The Clarity device enables immediate 24/7 analysis of brain activity and is FDA-cleared for continuous monitoring of seizures. With the close of this recent round, Ceribell has now raised an estimated $121M in capital.
Current Health develops and commercializes an end-to-end patient monitoring platform
The company’s platform combines telemedicine and remote patient monitoring, integrating data from multiple remote monitoring devices and the patient’s personal health record, to enable preventative healthcare, improve patient health outcomes, and reduce the cost of care. The Current Health platform integrates numerous data inputs into a single-view clinical dashboard. The company’s platform supports a range of monitoring services, including DexCom for continuous glucose monitoring and Omron’s iHealth blood pressure monitoring system.
CytoVeris – real-time, intraoperative detection of cancer
CytoVeris is developing TumorMAP, a Raman spectroscopy-based technique for the assessment of tumor margins during breast conserving surgery. The company plans to begin intraoperative deployment of their product in Q4 2021. To date, CytiVerus has raised approximately $3.7M to date. Other companies developing tumor margin assessment technologies include Clear-Cut Medical, ODS Medical, and SamanTree Medical.
CytoVeris is a presenting company at Life Science Intelligence’s 2021 Emerging Medtech Summit.
Harbor MedTech – regenerative tissue products for advanced wound healing
The company develops and commercializes products built on the company’s patented BriDGE technology. The proprietary platform transforms standard type-1 collagen into bio-friendly, stabilized collagen matrices that capable of stimulating the patient’s healing cascade. Harbor MedTech has raised approximately $5.8M over four rounds. CONMED, DePuy Synthes, and Smith & Nephew are some of the key strategics with biologics products for wound healing and sports medicine.
Harbor MedTech is a presenting company at Life Science Intelligence’s 2021 Emerging Medtech Summit.
Artio Medical – next-generation peripheral vascular and neurovascular embolization products
Artio Medical is developing a portfolio of solutions for the treatment of neurovascular and peripheral vascular diseases. The company’s platform is largely focused on using balloons and coils to immediately occlude cerebral and peripheral aneurysms. In addition to occlusion solutions, the company is developing a vein dilation system for use prior to the creation of vascular access sites in hemodialysis patients. In April 2021, Artio Medical raised $12M from a Series A round, bringing the company’s total funding amount to an estimated $27M.
Learn about the hottest venture funded startups developing innovative medical technologies using Life Science Intelligence’s Medtech Startup Tracker.
Schedule an exploratory call
Request Info© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy
